|Day Low/High||59.05 / 60.73|
|52 Wk Low/High||45.07 / 65.09|
We see a notable shift away from traditional large-cap pharmaceutical stocks to more specialized niches.
Integra hopes this deal will grow its revenue to $2 billion sooner than expected.
These new companies may offer some intriguing opportunities.